Journal of Chinese Pharmaceutical Sciences ›› 2023, Vol. 32 ›› Issue (2): 101-111.DOI: 10.5246/jcps.2023.02.008
• Original articles • Previous Articles Next Articles
Received:
2022-10-29
Revised:
2022-11-20
Accepted:
2022-12-14
Online:
2023-02-28
Published:
2023-02-28
Contact:
Yuhui Wei
Supporting: /attached/file/20230302/20230302162500_130.pdf
Zhi Rao, Yuhui Wei. A cell-combining-oriented phytochemical screening strategy using triple quadrupole mass spectrometry for the investigation of potential bioactive candidates in Chinese traditional medicine preparation Xiao-ai-ping injection[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(2): 101-111.
[1] |
Feng, F.C.; Huang, J.Y.; Wang, Z.C.; Zhang, J.R.; Han, D.; Wu, Q.; He, H.L.; Zhou, X.M. Xiao-ai-Ping injection adjunct with platinum-based chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis. . BMC Complement. Med. Ther. 2020, 20, 3.
|
[2] |
Chen, J.J.; Zhang, X.Q.; Xiao, X.; Ding, Y.W.; Zhang, W.; Shi, M.Z.; Yang, J.; Liu, Y.; Han, Y.L. Xiao-ai-Ping injection enhances effect of paclitaxel to suppress breast cancer proliferation and metastasis via activating transcription factor 3. Integr. Cancer Ther. 2020, 19, 1534735420906463.
|
[3] |
Hou, D.R.; Xiong, J.; Li, Y.; Peng, Y.H.; Xiong, L. Efficacy and safety of Xiaoaiping injection for liver cancer: a protocol for systematic review and meta-analysis. Medicine. 2020, 99, e21993.
|
[4] |
Hou, D.R.; Xiong, J.; Peng, Y.H.; Li, Y.; Xiong, L. Efficacy and safety of Xiaoaiping injection for breast cancer: a protocol for systematic review and meta-analysis. Medicine. 2020, 99, e21932.
|
[5] |
Qi, S.; Li, X.; Dong, Q.; Lai, H.Z.; Porter, D.; Tian, S.D.; Hou, L.; Chen, X.Y.; Li, X.K.; Wang, K. Chinese herbal medicine (Xiaoaiping) injections for chemotherapy-induced thrombocytopenia: a randomized, controlled, multicenter clinical trial. J. Altern. Complement. Med. 2019, 25, 648–655.
|
[6] |
Zhou, X.; Liu, M.L.; Ren, Q.; Zhu, W.F.; Wang, Y.; Chen, H.C.; Chen, J.R. Oral and injectable Marsdenia tenacissima extract (MTE) as adjuvant therapy to chemotherapy for gastric cancer: a systematic review. BMC Complement. Altern. Med. 2019, 19, 366.
|
[7] |
Yu, F.J.; Li, Y.M.; Zou, J.Q.; Jiang, L.S.; Wang, C.; Tang, Y.; Gao, B.; Luo, D.L.; Jiang, X.J. The Chinese herb Xiaoaiping protects against breast cancer chemotherapy-induced alopecia and other side effects: a randomized controlled trial. J. Int. Med. Res. 2019, 47, 2607–2614.
|
[8] |
Wu, K.R.; Zhu, Z.H.; He, Y.X.; Huang, L.L.; Yan, X.; Wang, D.W. Efficacy and safety of Xiao ai Ping injection combined with chemotherapy in advanced gastric cancer: a systematic review and meta-analysis. Evid. Based Complement. Alternat. Med. 2019, 2019, 3821053.
|
[9] |
Yu, N.; Wei, Y.L.; Zhu, Y.; Zhu, N.; Wang, Y.L.; Zhang, H.P.; Sun, A.D. Integrated approach for identifying and evaluating the quality of Marsdenia tenacissima in the medicine market. PLoS One. 2018, 13, e0195240.
|
[10] |
Hou, X.F.; Sun, M.; Bao, T.; Xie, X.Y.; Wei, F.; Wang, S.C. Recent advances in screening active components from natural products based on bioaffinity techniques. Acta Pharm. Sin. B. 2020, 10, 1800–1813.
|
[11] |
Liu, P.; Xu, D.W.; Li, R.T.; Wang, S.H.; Hu, Y.L.; Shi, S.Y.; Li, J.Y.; Huang, Y.H.; Kang, L.W.; Liu, T.X. A combined phytochemistry and network pharmacology approach to reveal potential anti-NSCLC effective substances and mechanisms in Marsdenia tenacissima (roxb.) moon (stem). Front. Pharmacol. 2021, 12, 518406.
|
[12] |
Zhu, R.J.; Shen, X.L.; Dai, L.L.; Ai, X.Y.; Tian, R.H.; Tang, R.; Hu, Y.J. Total aglycones from Marsdenia tenacissima increases antitumor efficacy of paclitaxel in nude mice. Molecules. 2014, 19, 13965–13975.
|
[13] |
Rao, Z.; Zhang, F.; Zhang, X.Y.; Zhang, G.Q.; Ma, Y.R.; Zhou, Y.; Qin, H.Y.; Wu, X.A.; Wei, Y.H. Multicomponent determination of traditional Chinese medicine preparation Yin-Zhi-Huang injection by LC-MS/MS for screening of its potential bioactive candidates using HepaRG cells. Biomed. Chromatogr. 2018, 32, e4057.
|
[14] |
Rao, Z.; Qin, H.Y.; Wei, Y.H.; Zhou, Y.; Zhang, G.Q.; Zhang, F.; Shao, Y.Y.; Huang, J.; Wu, X.A. Development of a dynamic multiple reaction monitoring method for determination of digoxin and six active components of Ginkgo biloba leaf extract in rat plasma. J. Chromatogr. B. 2014, 959, 27–35.
|
[15] |
Kang, D.; Ding, Q.Q.; Xu, Y.F.; Yin, X.X.; Guo, H.M.; Yu, T.J.; Wang, H.; Xu, W.S.; Wang, G.J.; Liang, Y. Comparative analysis of constitutes and metabolites for traditional Chinese medicine using IDA and SWATH data acquisition modes on LC-Q-TOF MS. J. Pharm. Anal. 2020, 10, 588–596.
|
[16] |
Wei, W.L.; Wu, S.F.; Li, H.J.; Li, Z.W.; Qu, H.; Yao, C.L.; Zhang, J.Q.; Li, J.Y.; Wu, W.Y.; Guo, D.A. Chemical profiling of Huashi Baidu prescription, an effective anti-COVID-19 TCM formula, by UPLC-Q-TOF/MS. Chin. J. Nat. Med. 2021, 19, 473–480.
|
[17] |
Li, H.; Yao, W.F.; Liu, Q.N.; Xu, J.; Bao, B.H.; Shan, M.Q.; Cao, Y.D.; Cheng, F.F.; Ding, A.W.; Zhang, L. Application of UHPLC-ESI-Q-TOF-MS to identify multiple constituents in processed products of the herbal medicine ligustri lucidi fructus. Molecules. 2017, 22, 689.
|
[18] |
Wu, X.; Zhu, L.; Ma, J.; Ye, Y.; Lin, G. Adduct ion-targeted qualitative and quantitative analysis of polyoxypregnanes by ultra-high pressure liquid chromatography coupled with triple quadrupole mass spectrometry. J. Pharm. Biomed. Anal. 2017, 145, 127–136.
|
[1] | Xiaowei Chi, Qi Li, Yi Zhong, Tong Gong, Chuxiao Yi, Liangren Zhang, Zhenming Liu. Discovery of potential xanthine oxidase inhibitors based on virtual screening [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(8): 626-635. |
[2] | Wen Ma, Yue Xu, Shuyuan Wang, Jun Li, Baoxue Yang. Research on accurate quantitation technique using liquid chromatography coupled with triple quadrupole mass spectrometry and experiment optimization—take a novel diuretic as an example [J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(3): 184-191. |
[3] | Guifang Duan, Bo Xu, Xia Yuan, Shuxiang Song. High-throughput screening technologies for ion channel drug discovery [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(10): 785-793. |
[4] | Chennan Liu, Qian Wang, Jiangxue Han, Sihan Liu, Chunling Xiao, Yan Guan, Xinghua Li, Ying Wang, Xiao Wang, Jianzhou Meng, Maoluo Gan, Yishuang Liu. Virtual screening and high-throughput testing of L1 metallo-β-lactamase inhibitor [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(10): 806-812. |
[5] | Hua Deng, Chao Gao, Dengguo Wei, Sisi Liu. Virtual screening for triple-negative breast cancer cell inhibitors based on telomere G-quadruplex structure [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(6): 383-389. |
[6] | Jiangxue Han, Chunling Xiao, Maoluo Gan, Xinghua Li, Ying Wang, Jiayin Zheng, Dongsheng Li, Chennan Liu, Yan Guan, Jianzhou Meng, Shuchao Huang, Yishuang Liu. IMB-XH1 identified as a novel inhibitor of New Delhi metallo-β-lactamase-1 [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(4): 238-246. |
[7] | Yishuang Liu, Jiayin Zheng, Shuchao Huang, Yan Guan, Chunling Xiao. Establishment and application of the screening model of the Mycobacterium tuberculosis β-lactamase BlaC inhibitors [J]. Journal of Chinese Pharmaceutical Sciences, 2016, 25(3): 189-195. |
[8] | Xiaodan Zhang, Chen Li, Kai Zhu, Yanmeng Liu, Ruijun Wu, Jinyu Ren, Xiaomei Ling. A new method of immobilizing HEK293 cells on the inner wall of a capillary column as stationary phase for drug screening [J]. Journal of Chinese Pharmaceutical Sciences, 2016, 25(11): 821-825. |
[9] | Xiwen Xue, Wenjie Zhu, Liangren Zhang, Yongjuan Zhao, Zhenming Liu. Comparison and discovery of potential non-covalent CD38 inhibitors by virtual screening strategy based on natural substrates and known inhibitors [J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(9): 572-580. |
[10] | Tingbo Ding, Jibin Dong, Bin Lou, Xian-Cheng Jiang. Sphingomyelin synthase activity measurement by the fluorescent product in cell culture medium or animal plasma [J]. Journal of Chinese Pharmaceutical Sciences, 2014, 23(4): 256-261. |
[11] | Yating Li, Yi Zheng, Delin Pan, Bo Xu, Yun Wu*, Zhenjun Yang, Lihe Zhang . Development of a high-content screening method to evaluate the cellular population-based biological activity of new siRNA delivering reagent [J]. Journal of Chinese Pharmaceutical Sciences, 2013, 22(6): 467-474. |
[12] | Xuan Jia, Xia Yuan, Mingming Chu, Fuxiang Ran, Runtao Li*, Jingrong Cui*. Cell cycle arrest effect of compound YSY-01A, a new proteasome inhibitor, on SK-OV-3 cells [J]. Journal of Chinese Pharmaceutical Sciences, 2013, 22(6): 483-490. |
[13] | Chao Li, Ying Guo, Chao Tian, Shouxin Zhou, Rufeng Yan, Zhili Zhang, Xiaowei Wang, Junyi Liu*. Expression, purification and activity assay of recombinant human thymidylate synthase [J]. , 2013, 22(2): 173-176. |
[14] | Li-Wei Wang, Yan-Fang Yang, Ying-Tao Zhang* . Application of a yeast two-hybrid based screening system in the identification of amyloid-beta aggregation inhibitors in pharmaceutical plants [J]. , 2011, 20(5): 510-517. |
[15] |
Xing-Xin Yang, Yan-Li Zhang, Xiao-Xia Zhang, Xiao-Ni Li*.
Cell membrane chromatography and its application in the analysis of bioactive ingredients of TCMs [J]. , 2011, 20(1): 20-25. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||